-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Tango Therapeutics, Raises Price Target to $18

Benzinga·02/06/2026 14:45:33
Listen to the news
Guggenheim analyst Michael Schmidt maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from $12 to $18.